FI972284A - cis-(+)-3-(4,6-dihydroksikroman-3-yylimetyyli)-4-metoksianiliinin valmistusmenetelmiä ja niissä käytettyjä välituotteita - Google Patents

cis-(+)-3-(4,6-dihydroksikroman-3-yylimetyyli)-4-metoksianiliinin valmistusmenetelmiä ja niissä käytettyjä välituotteita Download PDF

Info

Publication number
FI972284A
FI972284A FI972284A FI972284A FI972284A FI 972284 A FI972284 A FI 972284A FI 972284 A FI972284 A FI 972284A FI 972284 A FI972284 A FI 972284A FI 972284 A FI972284 A FI 972284A
Authority
FI
Finland
Prior art keywords
methoxyaniline
ylmethyl
cis
dihydroxycroman
compounds
Prior art date
Application number
FI972284A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972284A0 (fi
Inventor
George J Quallich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI972284A publication Critical patent/FI972284A/fi
Publication of FI972284A0 publication Critical patent/FI972284A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI972284A 1994-11-30 1997-05-29 cis-(+)-3-(4,6-dihydroksikroman-3-yylimetyyli)-4-metoksianiliinin valmistusmenetelmiä ja niissä käytettyjä välituotteita FI972284A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/346,955 US5539128A (en) 1994-11-30 1994-11-30 Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline
PCT/IB1995/000846 WO1996016955A1 (fr) 1994-11-30 1995-10-06 Procedes et intermediaires pour preparer une cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline

Publications (2)

Publication Number Publication Date
FI972284A true FI972284A (fi) 1997-05-29
FI972284A0 FI972284A0 (fi) 1997-05-29

Family

ID=23361728

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972284A FI972284A0 (fi) 1994-11-30 1997-05-29 cis-(+)-3-(4,6-dihydroksikroman-3-yylimetyyli)-4-metoksianiliinin valmistusmenetelmiä ja niissä käytettyjä välituotteita

Country Status (12)

Country Link
US (1) US5539128A (fr)
EP (1) EP0794951B1 (fr)
JP (1) JP3041049B2 (fr)
AT (1) ATE191715T1 (fr)
CA (1) CA2204604C (fr)
DE (1) DE69516305T2 (fr)
DK (1) DK0794951T3 (fr)
ES (1) ES2144628T3 (fr)
FI (1) FI972284A0 (fr)
GR (1) GR3033608T3 (fr)
PT (1) PT794951E (fr)
WO (1) WO1996016955A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
WO1990015801A1 (fr) * 1989-06-22 1990-12-27 Pfizer Inc. Sulfamides substitues et composes apparentes dans le traitement de l'asthme, de l'arthrite et des maladies apparentees
US4987231A (en) * 1989-08-04 1991-01-22 Pfizer Inc. Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol
WO1994008996A1 (fr) * 1992-10-21 1994-04-28 Pfizer Inc. Derives sulfonamides de composes heterocycliques et cycloalkyle substitues par hydroxy a fusion benzenique

Also Published As

Publication number Publication date
EP0794951A1 (fr) 1997-09-17
US5539128A (en) 1996-07-23
CA2204604C (fr) 2002-02-19
WO1996016955A1 (fr) 1996-06-06
JP3041049B2 (ja) 2000-05-15
JPH10500143A (ja) 1998-01-06
EP0794951B1 (fr) 2000-04-12
MX9703989A (es) 1997-09-30
GR3033608T3 (en) 2000-10-31
DK0794951T3 (da) 2000-07-10
PT794951E (pt) 2000-07-31
DE69516305T2 (de) 2001-02-15
FI972284A0 (fi) 1997-05-29
ES2144628T3 (es) 2000-06-16
ATE191715T1 (de) 2000-04-15
DE69516305D1 (de) 2000-05-18
CA2204604A1 (fr) 1996-06-06

Similar Documents

Publication Publication Date Title
CA2109613A1 (fr) Derives fluoroalcoxybenzylamines d'heterocycles azotes
ATE224374T1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
AU5169693A (en) Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
DE3681518D1 (de) Pyridinderivate, deren herstellung und anwendung.
FI931765A (fi) Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
CA2238283A1 (fr) Methode d'identification de composes visant a inhiber les lesions neoplasiques, compositions pharmaceutiques a prtir de ces composes et compositions pour traiter les lesions neoplasiques
DK0654041T3 (da) Peptidyl-4-amino-2,2-difluor-3-oxo-1,6-hexandisyre-derivater som anto-inflammatoriske midler
TR199500956A2 (tr) Benzimidazol türevleri.
AP9300578A0 (en) Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds.
FI972284A (fi) cis-(+)-3-(4,6-dihydroksikroman-3-yylimetyyli)-4-metoksianiliinin valmistusmenetelmiä ja niissä käytettyjä välituotteita
MA22926A1 (fr) Procede pour la preparation de nouveaux composes.
CA2083361A1 (fr) Production piscicole
DK0804186T3 (da) Indolditerpenalkaloidforbindelser
DE69310353D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze
CA2175352A1 (fr) 3-aryl-4-alkyl et 4,5-dialkyl-4h-1,2,4-triazoles permettant d'ameliorer la memoire
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
ES8308828A1 (es) "procedimiento para la preparacion de (+)-6-metoxi-x-metil-2-naftalen-acetato de n,n"-bis-(4-clorofenil)-1,12-diimino-2,4,11-13-tetraaza-tetradecandiimidoamida".
KR970702869A (ko) 항종양성 인돌로피롤로카르바졸 유도체(antitumor indolopyprolocarbazole derivative)
SE8800480D0 (sv) Arylamider av alfa-hexametyleniminokarbonsyror och hydroklorider av dessa arylamider
MY104184A (en) A sampled data phase locking system
TH13037EX (th) " สารประกอบใหม่ "